Information  X 
Enter a valid email address

Powderject Pharm (PJP)

  Print      Mail a friend

Thursday 12 September, 2002

Powderject Pharm

Director Shareholding

Powderject Pharmaceuticals PLC
12 September 2002



                       DEALINGS BY DIRECTORS


1)  NAME OF COMPANY

    POWDERJECT PHARMACEUTICALS PLC

2)  NAME OF DIRECTOR

    MR LARRY ELLBERGER

3)  Please state whether notification indicates that it is in respect of
    holding of the shareholder named in 2 above or in respect of a
    non-beneficial interest or in the case of an individual holder
    if it is a holding of that person's spouse or children under the
    age of 18 or in respect of an non-beneficial interest



4)  Name of the registered holder(s) and, if more than one holder, the
    number of shares held by each of them. (If notified)



5)  Please state whether notification relates to a person(s) connected
    with the Director named in 2 above and identify the connected person(s)



6)  Please state the nature of the transaction. For PEP transactions
    please indicate whether general/single co PEP and if discretionary/non
    discretionary



7)  Number of shares/amount of
    stock acquired



8)   (N/A %)
    of issued Class



9)  Number of shares/amount
    of stock disposed



10)  ( N/A %)
    of issued Class



11) Class of security



12) Price per share



13) Date of transaction



14) Date company informed



15) Total holding following this notification



16) Total percentage holding of issued class following this notification



     IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
                    COMPLETE THE FOLLOWING BOXES

17) Date of grant

    12TH SEPTEMBER 2002

18) Period during which or date on which exercisable

    12TH SEPTEMBER 2005 TO 11TH SEPTEMBER 2012

19) Total amount paid (if any) for grant of the option

    NIL

20) Description of shares or debentures involved: class, number.

    94,413 ORDINARY SHARES OF 10P EACH

21) Exercise price (if fixed at time of grant) or indication that price
    is to be fixed at time of exercise

    438.5 PENCE

22) Total number of shares or debentures over which options held
    following this notification

    294,413

23) Any additional information

    STANDARD PERFORMANCE CONDITIONS APPLY, PLUS CERTAIN ADDITIONAL SPECIFIC 
    CONDITIONS RELATED TO MR ELLBERGER'S BUSINESS OBJECTIVES

24) Name of contact and telephone number for queries

    NICK WENBAN SMITH   01865 332600

25) Name and signature of authorised company official responsible for
    making this notification

    Date of Notification    12TH SEPTEMBER 2002                             


                      This information is provided by RNS
            The company news service from the London Stock Exchange